Creo Medical Group PLC
LSE:CREO

Watchlist Manager
Creo Medical Group PLC Logo
Creo Medical Group PLC
LSE:CREO
Watchlist
Price: 18.6 GBX -0.8%
Market Cap: 76.7m GBX
Have any thoughts about
Creo Medical Group PLC?
Write Note

Intrinsic Value

CREO's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CREO stock under the Base Case scenario is 25.9 GBX. Compared to the current market price of 18.6 GBX, Creo Medical Group PLC is Undervalued by 28%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CREO Intrinsic Value
25.9 GBX
Undervaluation 28%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Creo Medical Group PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CREO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CREO?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Creo Medical Group PLC

Provide an overview of the primary business activities
of Creo Medical Group PLC.

What unique competitive advantages
does Creo Medical Group PLC hold over its rivals?

What risks and challenges
does Creo Medical Group PLC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Creo Medical Group PLC.

Provide P/S
for Creo Medical Group PLC.

Provide P/E
for Creo Medical Group PLC.

Provide P/OCF
for Creo Medical Group PLC.

Provide P/FCFE
for Creo Medical Group PLC.

Provide P/B
for Creo Medical Group PLC.

Provide EV/S
for Creo Medical Group PLC.

Provide EV/GP
for Creo Medical Group PLC.

Provide EV/EBITDA
for Creo Medical Group PLC.

Provide EV/EBIT
for Creo Medical Group PLC.

Provide EV/OCF
for Creo Medical Group PLC.

Provide EV/FCFF
for Creo Medical Group PLC.

Provide EV/IC
for Creo Medical Group PLC.

Show me price targets
for Creo Medical Group PLC made by professional analysts.

What are the Revenue projections
for Creo Medical Group PLC?

How accurate were the past Revenue estimates
for Creo Medical Group PLC?

What are the Net Income projections
for Creo Medical Group PLC?

How accurate were the past Net Income estimates
for Creo Medical Group PLC?

What are the EPS projections
for Creo Medical Group PLC?

How accurate were the past EPS estimates
for Creo Medical Group PLC?

What are the EBIT projections
for Creo Medical Group PLC?

How accurate were the past EBIT estimates
for Creo Medical Group PLC?

Compare the revenue forecasts
for Creo Medical Group PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Creo Medical Group PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Creo Medical Group PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Creo Medical Group PLC compared to its peers.

Compare the P/E ratios
of Creo Medical Group PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Creo Medical Group PLC with its peers.

Analyze the financial leverage
of Creo Medical Group PLC compared to its main competitors.

Show all profitability ratios
for Creo Medical Group PLC.

Provide ROE
for Creo Medical Group PLC.

Provide ROA
for Creo Medical Group PLC.

Provide ROIC
for Creo Medical Group PLC.

Provide ROCE
for Creo Medical Group PLC.

Provide Gross Margin
for Creo Medical Group PLC.

Provide Operating Margin
for Creo Medical Group PLC.

Provide Net Margin
for Creo Medical Group PLC.

Provide FCF Margin
for Creo Medical Group PLC.

Show all solvency ratios
for Creo Medical Group PLC.

Provide D/E Ratio
for Creo Medical Group PLC.

Provide D/A Ratio
for Creo Medical Group PLC.

Provide Interest Coverage Ratio
for Creo Medical Group PLC.

Provide Altman Z-Score Ratio
for Creo Medical Group PLC.

Provide Quick Ratio
for Creo Medical Group PLC.

Provide Current Ratio
for Creo Medical Group PLC.

Provide Cash Ratio
for Creo Medical Group PLC.

What is the historical Revenue growth
over the last 5 years for Creo Medical Group PLC?

What is the historical Net Income growth
over the last 5 years for Creo Medical Group PLC?

What is the current Free Cash Flow
of Creo Medical Group PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Creo Medical Group PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Creo Medical Group PLC

Current Assets 32.1m
Cash & Short-Term Investments 9.8m
Receivables 13.8m
Other Current Assets 8.5m
Non-Current Assets 37.2m
Long-Term Investments 2.1m
PP&E 8.5m
Intangibles 25.2m
Other Non-Current Assets 1.4m
Current Liabilities 9.9m
Accounts Payable 5.4m
Other Current Liabilities 4.5m
Non-Current Liabilities 12m
Long-Term Debt 10.7m
Other Non-Current Liabilities 1.3m
Efficiency

Earnings Waterfall
Creo Medical Group PLC

Revenue
30.3m GBP
Cost of Revenue
-15.3m GBP
Gross Profit
15m GBP
Operating Expenses
-40.1m GBP
Operating Income
-25.1m GBP
Other Expenses
2.7m GBP
Net Income
-22.4m GBP

Free Cash Flow Analysis
Creo Medical Group PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CREO Profitability Score
Profitability Due Diligence

Creo Medical Group PLC's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROIC is Increasing
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
25/100
Profitability
Score

Creo Medical Group PLC's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

CREO Solvency Score
Solvency Due Diligence

Creo Medical Group PLC's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
47/100
Solvency
Score

Creo Medical Group PLC's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CREO Price Targets Summary
Creo Medical Group PLC

Wall Street analysts forecast CREO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CREO is 76.5 GBX with a low forecast of 70.7 GBX and a high forecast of 84 GBX.

Lowest
Price Target
70.7 GBX
280% Upside
Average
Price Target
76.5 GBX
311% Upside
Highest
Price Target
84 GBX
352% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CREO?

Click here to dive deeper.

Dividends

Creo Medical Group PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for CREO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Creo Medical Group PLC Logo
Creo Medical Group PLC

Country

United Kingdom

Industry

Health Care

Market Cap

76.7m GBP

Dividend Yield

0%

Description

Creo Medical Group Plc operates as a medical device company that focuses on surgical endoscopy. The company is headquartered in Chepstow, Monmouthshire/Sir Fynwy and currently employs 245 full-time employees. The company went IPO on 2016-12-09. The firm focuses on the field of surgical endoscopy. The company is focused on the development and commercialization of minimally invasive electrosurgical devices. The firm has developed CROMA, which delivers bipolar radiofrequency (RF) energy for precise localized cutting and focused microwave (MW) energy for controlled coagulation and ablation through a single accessory port. The company has three initial areas of clinical focus, which include in the Gastrointestinal (GI) tract, soft tissue ablation (including but not limited to the liver, pancreas, kidney), and lung interventions for the resection and/or ablation of precancerous and cancerous lesions. The firm has four technology families, which include Speedboat, MicroBlate, SlypSeal and SpydrBlade.

Contact

MONMOUTHSHIRE/SIR FYNWY
Chepstow
Unit 2 Beaufort Park,, Beaufort Park Way
+441291606005.0
creomedical.com

IPO

2016-12-09

Employees

245

Officers

CEO & Executive Director
Mr. Craig Jonathan Gulliford
Founder, CTO & Executive Director
Prof. Christopher Paul Hancock
CFO & Executive Director
Mr. Richard John Rees ACA
Chief Commercial Officer & Executive Director
Mr. David Gerard Woods
Sales & Marketing Director
Mr. Phil Hales
Secretary
Mr. Richard Gary Craven

See Also

Discover More
What is the Intrinsic Value of one CREO stock?

The intrinsic value of one CREO stock under the Base Case scenario is 25.9 GBX.

Is CREO stock undervalued or overvalued?

Compared to the current market price of 18.6 GBX, Creo Medical Group PLC is Undervalued by 28%.

Back to Top